Home / Inspections / 1325654

FDA Inspection 1325654 — NewYork-Presbyterian Columbia Irving Medical Center

NewYork-Presbyterian Columbia Irving Medical Center — FEI 2474233

The FDA completed an inspection of NewYork-Presbyterian Columbia Irving Medical Center on July 2, 2026 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 2, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Facility

Other inspections at this facility

  • 1223803 (VAI Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1086853 (NAI Wed Apr 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1006752 (NAI Thu Apr 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 905645 (VAI Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 816284 (NAI Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources